- Report
- June 2024
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- October 2024
Global
From €3317EUR$3,500USD£2,771GBP
- Report
- December 2021
Global
From €4597EUR$4,850USD£3,840GBP
The Human T-cell Leukemia Virus (HTLV) testing market is a subset of the larger infectious disease testing market. HTLV testing is used to detect the presence of the virus in individuals, which can cause a variety of diseases, including adult T-cell leukemia/lymphoma and HTLV-associated myelopathy/tropical spastic paraparesis. HTLV testing is typically done through a blood test, and is used to diagnose and monitor the progression of the virus.
HTLV testing is used in a variety of settings, including clinical laboratories, hospitals, and research institutions. It is also used to screen blood donors for the virus, as well as to diagnose and monitor individuals who are at risk of infection.
Companies in the HTLV testing market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, and Siemens Healthineers. Show Less Read more